Period of time： 2012年3期
Publisher： Adis International
Founded in： 1994
Total resources： 114
ISSN： 1173-8804
Subject： R4 Clinical Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
BioDrugs,volume 17,issue 3
Menu
Access to resources
Recommend
Gangliosides as Therapeutic Targets for Cancer
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.Stealth Nucleosides: Mode of Action and Potential Use in the Treatment of Viral Diseases
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.Probiotics and Inflammatory Bowel Disease
By Kwon J.H., Farrell R.J. in (2003)
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.Role of Novel Biological Therapies in Psoriatic Arthritis: Effects on Joints and Skin
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.By Tripi S., Soresi M., Gaetano G.D., Carroccio A., Giannitrapani L., Vuturo O., Giovanni G.D., Montalto G. in (2003)
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
By Simpson D., Noble S., Perry C. in (2003)
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.Abetimus: Abetimus sodium, LJP 394
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy Introgen, RPR/INGN 201
BioDrugs,volume 17,issue 3 , Vol. 17, Iss. 3, 2003-01 , pp.
Previous
Next